{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:54:15Z","timestamp":1758052455413,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,14]]},"DOI":"10.7759\/cureus.92273","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:32:50Z","timestamp":1757856770000},"source":"Crossref","is-referenced-by-count":0,"title":["Hemodynamic Changes Following Landiolol Initiation in Patients With Critical Illness Who Developed Tachycardia During Dobutamine Infusion: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Daichi","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-017-0264-6","article-title":"Time to re-think the use of dobutamine in sepsis","volume":"5","author":"Sato R","year":"2017","unstructured":"Sato R, Nasu M. Time to re-think the use of dobutamine in sepsis. J Intensive Care. 2017, 5:65. 10.1186\/s40560-017-0264-6","journal-title":"J Intensive Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06852-8","article-title":"The effect of dobutamine in sepsis: a propensity score matched analysis","volume":"21","author":"Zhu Y","year":"2021","unstructured":"Zhu Y, Yin H, Zhang R, Ye X, Wei J. The effect of dobutamine in sepsis: a propensity score matched analysis. BMC Infect Dis. 2021, 21:1151. 10.1186\/s12879-021-06852-8","journal-title":"BMC Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318173026f","article-title":"Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses","volume":"108","author":"Fellahi JL","year":"2008","unstructured":"Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology. 2008, 108:979-87. 10.1097\/ALN.0b013e318173026f","journal-title":"Anesthesiology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16040517","article-title":"An overview of the pharmacokinetics and pharmacodynamics of landiolol (an ultra-short acting \u03b21 selective antagonist) in atrial fibrillation","volume":"16","author":"Floria M","year":"2024","unstructured":"Floria M, Oancea AF, Morariu PC, et al.. An overview of the pharmacokinetics and pharmacodynamics of landiolol (an ultra-short acting \u03b21 selective antagonist) in atrial fibrillation. Pharmaceutics. 2024, 16:14-6. 10.3390\/pharmaceutics16040517","journal-title":"Pharmaceutics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000285","article-title":"The myocardial oxygen supply:demand index revisited","volume":"3","author":"Hoffman JI","year":"2014","unstructured":"Hoffman JI, Buckberg GD. The myocardial oxygen supply:demand index revisited. J Am Heart Assoc. 2014, 3:e000285. 10.1161\/JAHA.113.000285","journal-title":"J Am Heart Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1025","article-title":"Blood pressure recovery after dobutamine antagonism: partial with landiolol, none with esmolol","volume":"11","author":"Krumpl G","year":"2022","unstructured":"Krumpl G, Ul\u010d I, Trebs M, Kadlecov\u00e1 P, Hodisch J, Husch B. Blood pressure recovery after dobutamine antagonism: partial with landiolol, none with esmolol. Clin Pharmacol Drug Dev. 2022, 11:309-17. 10.1002\/cpdd.1025","journal-title":"Clin Pharmacol Drug Dev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-020-00462-x","article-title":"Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults","volume":"21","author":"Krumpl G","year":"2020","unstructured":"Krumpl G, Ul\u010d I, Trebs M, Kadlecov\u00e1 P, Hodisch J. Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults. BMC Pharmacol Toxicol. 2020, 21:82. 10.1186\/s40360-020-00462-x","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/cc5007","article-title":"SOFA is superior to MOD score for the determination of non-neurologic organ dysfunction in patients with severe traumatic brain injury: a cohort study","volume":"10","author":"Zygun D","year":"2006","unstructured":"Zygun D, Berthiaume L, Laupland K, Kortbeek J, Doig C. SOFA is superior to MOD score for the determination of non-neurologic organ dysfunction in patients with severe traumatic brain injury: a cohort study. Crit Care. 2006, 10:R115. 10.1186\/cc5007","journal-title":"Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.09.27","article-title":"The hemodynamic effects of norepinephrine: far more than an increase in blood pressure!","volume":"6","author":"Foulon P","year":"2018","unstructured":"Foulon P, De Backer D. The hemodynamic effects of norepinephrine: far more than an increase in blood pressure!. Ann Transl Med. 2018, 6:S25. 10.21037\/atm.2018.09.27","journal-title":"Ann Transl Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03960-y","article-title":"Dopamine use and its consequences in the intensive care unit: a cohort study utilizing the Japanese Intensive care PAtient Database","volume":"26","author":"Suzuki R","year":"2022","unstructured":"Suzuki R, Uchino S, Sasabuchi Y, Kawarai Lefor A, Sanui M. Dopamine use and its consequences in the intensive care unit: a cohort study utilizing the Japanese Intensive care PAtient Database. Crit Care. 2022, 26:90. 10.1186\/s13054-022-03960-y","journal-title":"Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.70087","article-title":"Remifentanil use in intensive care units: current evidence and future perspectives","volume":"12","author":"Okano H","year":"2025","unstructured":"Okano H, Okamoto H, Sakuraya M, Aoki Y. Remifentanil use in intensive care units: current evidence and future perspectives. Acute Med Surg. 2025, 12:e70087. 10.1002\/ams2.70087","journal-title":"Acute Med Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12915","article-title":"Cardiac effects of opioid therapy","volume":"16","author":"Chen A","year":"2015","unstructured":"Chen A, Ashburn MA. Cardiac effects of opioid therapy. Pain Med. 2015, 16:S27-31. 10.1111\/pme.12915","journal-title":"Pain Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101769","article-title":"Hemodynamic effects of propofol","volume":"4","author":"Li B","year":"2025","unstructured":"Li B, Pop C, Johnson M, Sklar MC, Lawler PR, Elliott AM. Hemodynamic effects of propofol. JACC Adv. 2025, 4:101769. 10.1016\/j.jacadv.2025.101769","journal-title":"JACC Adv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine","volume":"56","author":"Weerink MA","year":"2017","unstructured":"Weerink MA, Struys MM, Hannivoort LN, Barends CR, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017, 56:893-913. 10.1007\/s40262-017-0507-7","journal-title":"Clin Pharmacokinet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-74075-1","article-title":"Model Based Inference in the Life Sciences: A Primer on Evidence","author":"Anderson DR","year":"2008","unstructured":"Anderson DR. Model Based Inference in the Life Sciences: A Primer on Evidence. Springer, New York, NY; 2008. 10.1007\/978-0-387-74075-1"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-012-0263-4","article-title":"Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery","volume":"28","author":"Nishi H","year":"2013","unstructured":"Nishi H, Sakaguchi T, Miyagawa S, et al.. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery. Heart Vessels. 2013, 28:490-6. 10.1007\/s00380-012-0263-4","journal-title":"Heart Vessels"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/sux037","article-title":"Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting","volume":"20","author":"Domanovits H","year":"2018","unstructured":"Domanovits H, Wolzt M, Stix G. Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting. Eur Heart J Suppl. 2018, 20:A1-3. 10.1093\/eurheartj\/sux037","journal-title":"Eur Heart J Suppl"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199907000-00012","article-title":"Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol","volume":"34","author":"Sugiyama A","year":"1999","unstructured":"Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol. 1999, 34:70-7. 10.1097\/00005344-199907000-00012","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.01.009","article-title":"Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials","volume":"159","author":"Hasegawa D","year":"2021","unstructured":"Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Takahashi K, Yatabe T, Nishida O. Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials. Chest. 2021, 159:2289-300. 10.1016\/j.chest.2021.01.009","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-021-00552-w","article-title":"\u03b21-blocker in sepsis","volume":"9","author":"Hasegawa D","year":"2021","unstructured":"Hasegawa D, Sato R, Nishida O. \u03b21-blocker in sepsis. J Intensive Care. 2021, 9:39. 10.1186\/s40560-021-00552-w","journal-title":"J Intensive Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/joa3.12934","article-title":"Landiolol, an intravenous \u03b21-selective blocker, is useful for dissociating a fusion of atrial activation via accessory pathway and atrioventricular node","volume":"39","author":"Kinjo T","year":"2023","unstructured":"Kinjo T, Kimura M, Kaname N, et al.. Landiolol, an intravenous \u03b21-selective blocker, is useful for dissociating a fusion of atrial activation via accessory pathway and atrioventricular node. J Arrhythm. 2023, 39:937-46. 10.1002\/joa3.12934","journal-title":"J Arrhythm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405007-hemodynamic-changes-following-landiolol-initiation-in-patients-with-critical-illness-who-developed-tachycardia-during-dobutamine-infusion-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:32:51Z","timestamp":1757856771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405007-hemodynamic-changes-following-landiolol-initiation-in-patients-with-critical-illness-who-developed-tachycardia-during-dobutamine-infusion-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,14]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.92273","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,14]]}}}